Broadcom is the most dangerous competitor the NVIDIA bulls underestimate — the named beneficiary of the one thing NVIDIA's own disclosures concede it loses, commodity inference to custom silicon, growing AI revenue +143% off a multi-year backlog of hyperscaler design wins. It is also the most expensive and lowest-quality way to own that thesis. Broadcom trades at a premium to NVIDIA on every earnings multiple while earning a third of the return on equity; its non-GAAP earnings are flattered by billions in acquisition amortization; it carries roughly $64B of debt; and it is exposed to the very same hyperscaler capex cycle as NVIDIA, in the same customers. The −13% beat-and-fall in June is the market reminding everyone the premium leaves no room for a merely-excellent quarter. We are WATCHING, not buying: a great business and the right structural thesis, but we would rather own the chokepoints than the levered, premium-priced challenger until the multiple resets or the FY27 AI number de-risks.
Reviewed 9 Oct 2026 against the falsifier on this page. Neither limb has fired. AI revenue arrived ahead of guidance (FQ3 AI semiconductor revenue $16.7B, +221%; FY27 AI outlook raised to about $115B, Broadcom release 2 Sep), yet the stock sits 6.3% below the call price ($367.45 on 9 Oct against $392.16), so the waiting has not cost a move. No hyperscaler has re-bid or taken in-house a Broadcom XPU programme. Of the two things this call said it was waiting for, the FY27 AI number has now de-risked. The watch now waits on the other one alone: Broadcom's earnings multiple ceasing to trade at a premium to NVIDIA's while it earns a fraction of NVIDIA's return on equity. The FQ4 print in December is the next check. Insider filings over the last 30 days show one director sale under a 10b5-1 plan adopted in December 2025, and no buys. KEEP as WATCHING, conviction MEDIUM.


